Back
Speaker illustration

Doctor Maurizio Bertaina

Torino North Emergency San Giovanni Bosco, Turin (Italy)

Member of:

Association for Acute CardioVascular Care
Heart Failure Association of the ESC

Dr. Maurizio Bertaina is a cardiologist at San Giovanni Bosco Hospital in Turin, Italy, working in the Cardiology Intensive Care Unit and Heart Failure service. He graduated in Cardiology at the University of Turin and subsequently completed a University Master’s Degree in Cardiac Intensive Care at the University of Padova, along with the Postgraduate Course in Heart Failure (PCHF) at Zurich University endorsed by the ESC Heart Failure Association. His clinical and research focus includes acute decompensated heart failure, cardiogenic shock, temporary mechanical circulatory support, invasive hemodynamic monitoring, chronic heart failure therapies and their impact on functional capacity, as well as pulmonary hypertension. He serves as Principal Investigator of multiple international observational studies and has participated as co-Principal Investigator in randomized controlled trials. He published extensively in international peer-reviewed journals and served as reviewer as well.

Presentations Articles

The impact of sex on outcomes and interaction with temporary mechanical circulatory support in cardiogenic shock: insights from the Altshock-2 Registry

Event: ESC Acute CardioVascular Care 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Predicting, assessing and managing cardiogenic shock

Access
Like
Thumbnail

Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: a systematic review and meta-analysis of observational studies

Event: Heart Failure 2021

Topic: Cardiogenic Shock

Session: Coronary Artery Disease, Acute Coronary Syndromes and Cardiogenic Shock

Access
Like
Thumbnail

Prognostic impact of MitraClip in patients with left ventricular dysfunction and functional mitral valve regurgitation: a comprehensive meta-analysis of RCTs and adjusted observational studies.

Event: Heart Failure 2019

Topic: Treatment

Session: Valvular Heart Disease

Access
Like
Thumbnail

Prasugrel vs Ticagrelor in patients with acute coronary syndrome and diabetes: a propensity match substudy of RENAMI

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Oral P2Y12 inhibitors in acute coronary syndromes: are they all equal?

Access
Like
Thumbnail

Complete or culprit only revascularization in patients with multivessel disease presenting with cardiogenic shock: a meta-analysis of RCT and adjusted observational results.

Event: ESC Congress 2018

Topic: Shock

Session: Acute coronary syndrome miscellaneous

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources